THE URBAN INSTITUTE The Future of Private Plan Contracting In Medicare – A Reprise Robert A. Berenson, M.D., NASI Conference: Medicare Modernization in.

Slides:

Advertisements

Similar presentations

Optima Medicare (PPO) Plans CY Medicare Medicare is a Federal health insurance program for those age 65 or older or individuals at any age who have.

Advertisements

THE COMMONWEALTH FUND Medicares Future: What Does It Hold? Stuart Guterman Assistant Vice President Director, Program on Payment System Reform The Commonwealth.

Medicare Advantage Payment System Mark Miller, PhD Medicare Payment Advisory Commission May 4, 2009.

Medicare and Prescription Drugs: Issues for Employers and Consumers Robert D. Reischauer The Urban Institute National Health Policy Conference January.

Adam J. Falk, Esq. FELDESMAN TUCKER LEIFER FIDELL LLP Legal issues for Medicaid Plans Under Part D in Serving Dual Eligibles MEDICAID HEALTH PLANS OF AMERICA.

Affordable Care Act Lowered Medicare Beneficiary Costs Based on an HHS report, “the 2010 health care law will save Medicare beneficiaries $59 billion through.

1 Controlling Costs in Medicare Jack Hoadley Research Professor Georgetown University Health Policy Institute Citizens’ Health Care Working Group Public.

MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.

Setting a Context for Medicare Spending

Affordable Care Act & Older Adults Presented By: Kristen Benevides, Sherry Tanaka, Malloree Ullrich, & Abraleen Keliinui.

“Serving the senior market since 1982”. Source: CMS National Training Program Medicare 101 Introduction to Medicare Original Medicare Plan Medicare Supplement.

Y0096_MRK_IL_MAEDPPT15. Today’s Topics Medicare Basics Medicare Advantage (MA) Plans Eligibility and Enrollment periods 2.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.

Medicare 101 Christian Reformed Church. June, Medicare 101 Introduction to Medicare Original Medicare Plan Medicare Supplement Insurance (Medigap)

U.S. Private Insurance Solutions in the US Social Insurance System for the Aged and Disabled March 5, 2015 David S. Abernethy 1.

What Employers and Employees Need to Know About Medicare Legislation and Eligibility Presented by, Jeff Johnson RHU, CEBS Brown and Brown Insurance.

Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.

Copyright © 2006 by The Segal Group, Inc., the parent of The Segal Company. All rights reserved. Options for Employers to Provide Retiree Coverage Post-

TAYLOR MELANSON Providing Prescription Drug Coverage to the Elderly: America’s Experiment with Medicare Part D By Mark Duggan, Patrick Healy, and Fiona.

MEDICARE PART D: PAST AND PRESENT Juliette Cubanski, Ph.D. Associate Director, Program on Medicare Policy The Henry J. Kaiser Family Foundation MAPRx Congressional.

2014 Medicare Advantage Plans  Introduction  Eligibility  Basics of Medicare: 4 Parts: Original Medicare basics (Parts A and B) and limitations Medicare.

Strategic Implications of the New Medicare Prescription Drug Legislation G. Lawrence Atkins, PhD Schering-Plough Corporation The Pharma, Biotech and Device.

Michael Fiore, Director Division of Plan Policy Centers for Medicare and Medicaid Services June 6, 2006 Innovations in Medicare Managed Care for Dual Eligible.

MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?

MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.

There’s So Much More to Medicare, Let’s Talk Humana Medicare Advantage Health and Prescription Drug Plans M0006_GH210S6RR KC0906.

(c) 2012 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.

The AIDS Institute The Impact of Essential Health Benefits on People Living with HIV/AIDS Carl Schmid Deputy Executive Director ADAP Advocacy Association.

Issues and Challenges Facing Medicare Mark L. Hayes.

Medicare Advantage Overview Diane Rowland, Sc.D. Executive Vice President Kaiser Family Foundation Alliance for Health Reform July 16, 2007.

NOTES: Numbers may not sum to total due to rounding. People with disabilities under age 65 were not eligible for Medicare prior to SOURCE: Centers.

THE EMPLOYER’S ROLE IN MEDICARE Henry de Vos Lawrie, Jr.Kathryn J. Greenlief McGuire Woods BattleUSAA & Boothe LLP.

Medicare, Medicaid, and Health Care Reform Todd Gilmer, PhD Professor of Health Policy and Economics Department of Family and Preventive Medicine 1.

1 MEDICARE ADVANTAGE PLANS: MEDICARE COSTS IN 2007 Brian Biles, MD, MPH Department of Health Policy George Washington University June 3, 2007.

1 Factors Associated with Regional Variation in Medicare Part D Prescription Drug Plan Participation and Beneficiary Leslie M. Greenwald, Ph.D. Principal.

STATE PERSPECTIVES ON IMPLEMENTATION OF MEDICARE PART D: COORDINATING MEDICARE AND MEDICAID COVERAGE THROUGH SPECIAL NEEDS PLANS James M. Verdier Mathematica.

Bruce C. Vladeck, Ph.D. Physicians for a National Health Program Boston, MA November 2, 2013.

The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.

1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.

11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.

Return to Tutorials Tricia Neuman, Sc.D. Director, Medicare Policy Project Vice President, Kaiser Family Foundation For KaiserEDU June 2009 Medicare 101:

Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.

1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.

 December 4, /21/  Let’s have a constructive conversation! o If you have a personal complaint, please table it for post-discussion,

Dual Eligibles and Medicare: Ongoing Issues California Medicare Coalition Webcast – April 9, 2008 Presented by David Lipschutz California Health Advocates.

National Academy of Social Insurance 17 th Annual Conference Washington, D.C. January 28, 2005 Is There a Better Way to Reduce Growth in Medicare Spending?

HealthCare.gov is a consumer website, through and through -- in look, feel, content, and user experience. It’s all about you.

Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.

Understanding the A, B, C and D’s of Medicare 2013 A, B, C and D’s of Medicare 2013 Lisa Lettenmaier.

The Value of Medicare Advantage Karen Ignagni President and CEO America’s Health Insurance Plans July 16, 2007.

Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.

The Future of Medicare Advantage The Heritage Foundation September 10, 2008 James C. Capretta Fellow, Ethics and Public Policy Center

Figure 1 K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Dual Eligibles: The Basics Barbara Lyons, Ph.D. Director, Kaiser Commission on.

Alliance for Health Reform/Kaiser Family Foundation Washington, DC July 16, 2007 Medicare Advantage: Restructure Payments for Results Joseph Antos, Ph.D.

1 State Options for Supplementing Medicare Part D Drug Coverage Invitational Summit on Medicare Part D Implementation Issues Jack Hoadley Georgetown University.

ENHANCING VALUE IN MEDICARE Brian Biles, MD, MPH The George Washington University January 14, 2007.

Saving Medicare: watching our back while looking forwards Laura S. Boylan, MD Assistant Professor of Neurology Bellevue Hospital Center, New York University.

Special Needs Plans Sandra Bastinelli, MS, RN Acting Director, Division of Special Programs Medicare Advantage Group Center for Beneficiary Choices.

The Commonwealth Fund Alliance for Health Reform Washington DC Medicare as a Building Block for Health Reform: Should Americans Buy In? June 6, 2008 Steven.

John R. Kasich, Governor Mary Taylor, Lt. Governor/Director Presented by Medicare & You.

1 Providing Effective Community- Based LTC in a Managed Care Environment Mary Guthrie, MBA.

Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.

Medicare- Parts A, B, C and D

Medicare and Medicaid Week 3.

MMA, Private Plans, and Competition: Commercial Health Plan Response to MMA November 1, 2005 David F. Ogden, F.S.A. Milliman, Inc.

Paying for Serious Illness Care Under a Global Budget: Opportunities and Challenges Anna Gosline, Senior Director of Health Policy and Strategic Initiatives,

The Third National Medicare Congress David B. Snow, Jr.

The Role of the Private Sector in Part D

Discussion Topics History of Private Plans in Medicare

Presentation transcript:

THE URBAN INSTITUTE The Future of Private Plan Contracting In Medicare – A Reprise Robert A. Berenson, M.D., NASI Conference: Medicare Modernization in a Polarized Environment 27 January 2005

THE URBAN INSTITUTE Possible Objectives of Private Plan Contracting in Medicare Decreased government spending Additional benefits without new entitlements Positive spillover effects Enhanced choice for beneficiaries Improve capacity for innovation -- Berenson and Dowd, July 2002, AARP PPI Report

THE URBAN INSTITUTE A Post MMA Report Card– Decreased Government Spending MA plans are paid about 116% of what traditional Medicare would spend on the same person Because significant MA enrollment, a major new budget cost (CMS-OACT point of view) Because insignificant enrollment, not a major new budget cost (CBO position) Will the 2006 bidding model reduce government outlays? Doubtful

THE URBAN INSTITUTE Additional Benefits Without New Entitlements There is a rather expensive, if doughnut holed, new Part D benefit, as well as certain other benefit enhancements, such as routine physical for age-ins. TrOOP (true out of pocket) costs limit MA plans from offering supplemental Rx benefits With “excess,” plans still able to offer additional benefits --- the main additional benefit being cost-sharing buy-down

THE URBAN INSTITUTE Positive Spillover Effect Also includes a related concept of “benchmark competition,” e.g., the USP and Fed-Ex MedPAC, CMS have been actively looking for lessons from health plans for traditional Medicare (but not necessarily just from Medicare plans); spillover can occur to some extent from commercial plans to Medicare Increasing geographic penetration of MA plans could stimulate greater benchmark competition, but from PPOs and private FFS?

THE URBAN INSTITUTE Enhanced Choice for Beneficiaries The apparent major objective of MMA – even at increased cost But do regional PPOs satisfy the kind of choice that beneficiaries desire from plans, e.g., to keep their alternative delivery system into Medicare and to get additional benefits? That is, do people value PPO choice itself or the provider choice that PPOs permit commercially and Medicare already provides?

THE URBAN INSTITUTE Improved Capacity for Innovation It appears that large health plans are best positioned to seek to become stand-alone drug plans (PDPs) in traditional Medicare, as well as MA-PDs Section 721 is a major pilot of disease management, with some health plans being the winning bidders – in some ways health plans are better positioned than D.M. companies to support chronic care management in Medicare

THE URBAN INSTITUTE Other Implicit MMA-Related Rationales for Private Plans To permit management of a drug benefit within a medical management context to better promote quality and efficiency To substitute private monopsonists, less encumbered by procedure and politics, for traditional Medicare To provide a structural replacement that incorporates the role of and substitutes for traditional Medicare

THE URBAN INSTITUTE The Unstated “Logic” of the MMA 1. Expand private plan options to everywhere 2. Initially, pay lots more to private plans so that providers get paid more and beneficiaries get more 3. Traditional Medicare “withers on the vine” -- it dies a natural death, without political fingerprints 4. With an FEHBP structure firmly in place, install premium support/defined contribution to control government spending (with or without a “comparative cost adjustment” demonstration)